Hyaluronic acid results in improved knee OA pain symptoms compared to 6-methylprednisolone .
Intra-articular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methyl prednisolone acetate
Clin Exp Rheumatol. 1991 Jul-Aug;9(4):375-8140 knee osteoarthritis (OA) patients were randomized to undergo treatment with intra-articular injections of either sodium hyaluronate (NaHA) or 6-methylprednisolone (6-MPH). The purpose of the study was to compare the two interventions in terms of pain, stiffness, function, and tolerability. Although significantly greater benefits were reported for pain outcomes in patients undergoing treatment with NaHA, stiffness and function remained comparable between the groups. The treatment was well tolerated by all patients.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
